18/03/2022 (Agence Europe) – The European Commission proposed, on Friday 18 March to the Member States and the European Parliament in a delegated act, to ban two new drug substances in the EU, 3-MMC (3-Methylmethcathinone) and 3-CMC (3-Chloromethcathinone), psychostimulants that are dangerous because of their toxicity, according to a statement. They have been available in the EU “since at least 2012 and 2014, respectively. Both substances are mainly sold as powders, but are also available as tablets and capsules”, 27 deaths associated with 3-MMC were reported in five Member States and 10 deaths associated with 3-CMC in two Member States. In 2020, the Commission had already banned isotonitazene and MDMB-4in-PINACA and 4F-MDMB-BICA in 2021. The delegated act will be adopted if no objections are raised within 2 months. Member States will then have 6 months to transpose the ban. (SP)